Minimally invasive therapies for benign prostatic hyperplasia

Area of Science:

• Urology
• Medical Devices
• Minimally Invasive Procedures

Background:

• Benign prostatic hyperplasia (BPH) affects many men, with treatments including medication, minimally invasive options, and surgery.
• Transurethral technologies have expanded for BPH treatment, aiming for symptom relief without major complications.
• Minimally invasive therapies offer an alternative to surgery and medication, potentially reducing side effects and improving compliance.

Purpose of the Study:

• To define minimally invasive therapies for BPH.
• To present differences in catheter design and technique for these procedures.
• To discuss the pathologic basis, advantages, and disadvantages of each therapeutic option.

Main Methods:

• Review and comparison of various minimally invasive BPH treatment technologies.
• Analysis of catheter design and procedural techniques.
• Evaluation of clinical outcomes including symptom scores, peak flow, and quality of life.

Main Results:

• Clinically, symptom score, peak flow, and quality-of-life improvements are similar across minimally invasive techniques.
• Differences exist in the ability to achieve maximum responders and response duration.
• Techniques vary in their need for analgesia/sedation.

Conclusions:

• Urologists need a clear understanding of minimally invasive BPH therapies to guide clinical decisions.
• Optimal patient selection and realistic expectations are crucial for maximizing treatment effectiveness and durability.
• Science, not marketing, should drive the understanding of these BPH treatment options.